Sale!

HLA Pre-Transplant Workup Panel 2 Test

Name: HLA Pre-Transplant Workup Panel 2 Test
SKU: TEST-813
Price: 4800 AED
Availability: InStock

Original price was: 6,400 د.إ.Current price is: 4,800 د.إ.

-25%

The HLA Pre-Transplant Workup Panel 2 Test is a critical diagnostic tool used in the preparation for organ and tissue transplantation. This comprehensive test is performed to ensure compatibility between the donor and recipient, thereby reducing the risk of transplant rejection. HLA, or Human Leukocyte Antigen, testing is crucial for identifying the specific antigens on the surface of cells that can trigger an immune response in the recipient’s body.

Performed at DNA Labs UAE, a facility renowned for its advanced diagnostic services, the HLA Pre-Transplant Workup Panel 2 Test involves a series of sophisticated assays to analyze the HLA genes of both donor and recipient. This test is pivotal in matching organ donors with recipients in transplant medicine, making it an indispensable part of the pre-transplant evaluation process.

The cost of the HLA Pre-Transplant Workup Panel 2 Test at DNA Labs UAE is 4800 AED. This investment is crucial for the success of transplant procedures, as it significantly increases the chances of compatibility, thereby enhancing the long-term outcomes for transplant recipients. With its state-of-the-art technology and expert team, DNA Labs UAE ensures precise and reliable results, providing a solid foundation for successful transplantation.

Description

HLA PRE-TRANSPLANT WORKUP PANEL 2 Test

Test Name: HLA PRE-TRANSPLANT WORKUP PANEL 2 Test

Components: HLA-A, HLA-B, HLA-C, HLA-DR, HLA-DQ

Price: 4800.0 AED

Sample Condition: RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Report Delivery: 10-12 days

Method: Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry

Test type: Transplantation

Doctor: Nephrologist

Test Department:

Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Test Details:

HLA Pre-Transplant Workup Panel 2 test is a blood test that is performed to determine the compatibility between a potential organ donor and recipient. This test is usually done before a kidney transplant, but it can also be done for other types of organ transplants. The test analyzes the Human Leukocyte Antigen (HLA) system, which is a group of proteins found on the surface of white blood cells. These proteins help the immune system identify which cells are part of the body and which are foreign. The HLA Pre-Transplant Workup Panel 2 test looks at a specific set of HLA proteins, including HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ. By comparing the HLA profiles of the donor and recipient, doctors can determine the likelihood of the recipient’s immune system rejecting the transplanted organ. The test involves taking a blood sample from both the donor and recipient and analyzing it in a laboratory. The results are reported as a percentage match between the two individuals, with a higher percentage indicating a better match. Overall, the HLA Pre-Transplant Workup Panel 2 test is an important tool for ensuring the success of organ transplantation and reducing the risk of rejection.

Test Name	HLA PRE-TRANSPLANT WORKUP PANEL 2 Test
Components
Price	4800.0 AED
Sample Condition	RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery	10-12 days
Method	Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry
Test type	Transplantation
Doctor	Nephrologist
Test Department:
Pre Test Information	Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details	HLA Pre-Transplant Workup Panel 2 test is a blood test that is performed to determine the compatibility between a potential organ donor and recipient. This test is usually done before a kidney transplant, but it can also be done for other types of organ transplants. The test analyzes the Human Leukocyte Antigen (HLA) system, which is a group of proteins found on the surface of white blood cells. These proteins help the immune system identify which cells are part of the body and which are foreign. The HLA Pre-Transplant Workup Panel 2 test looks at a specific set of HLA proteins, including HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ. By comparing the HLA profiles of the donor and recipient, doctors can determine the likelihood of the recipient’s immune system rejecting the transplanted organ. The test involves taking a blood sample from both the donor and recipient and analyzing it in a laboratory. The results are reported as a percentage match between the two individuals, with a higher percentage indicating a better match. Overall, the HLA Pre-Transplant Workup Panel 2 test is an important tool for ensuring the success of organ transplantation and reducing the risk of rejection.